+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Spatial Genomics & Transcriptomics Market by Product, Sequencing Method, Application, End-User - Global Forecast 2025-2030- Product Image
Spatial Genomics & Transcriptomics Market by Product, Sequencing Method, Application, End-User - Global Forecast 2025-2030- Product Image
Sale

Spatial Genomics & Transcriptomics Market by Product, Sequencing Method, Application, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • March 2025
  • Region: Global
  • 360iResearch™
  • ID: 6012040
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Spatial Genomics & Transcriptomics Market grew from USD 1.05 billion in 2023 to USD 1.18 billion in 2024. It is expected to continue growing at a CAGR of 12.35%, reaching USD 2.38 billion by 2030.

Spatial genomics and transcriptomics represent a groundbreaking horizon in the biosciences, merging advanced imaging techniques and next-generation sequencing to map biological information at an unprecedented resolution. This integrated approach offers a multidimensional view of tissue architecture and molecular expression patterns, enabling researchers to decode complex biological systems that were once elusive. By capturing the spatial context in which cells operate and interact, experts are better positioned to understand not only the genetic basis underlying various diseases but also the microenvironmental cues that guide cellular function.

In today’s rapidly evolving scientific landscape, this field is steadily transforming traditional research paradigms. The ability to pinpoint where specific gene expressions occur within individual cells can unlock insights into tumor microenvironments, neurobiological processes, and developmental biology. This introductory overview lays the foundation for understanding the key technological advancements and analytic breakthroughs, while underscoring the imperative of adopting these innovations in both academic research and the pharmaceutical industry.

As this technology integrates with established methodologies, it is paving the way for bespoke diagnostic assessments and tailored therapies. The convergence of data science with spatial analysis is not only redefining experimental design but also inspiring more precise and effective interventions, placing spatial genomics and transcriptomics at the vanguard of future biomedical research.

Transformative Shifts in the Spatial Genomics Landscape

Over recent years, the landscape of spatial genomics and transcriptomics has undergone transformative shifts, driven by rapid advancements in computational biology, imaging technology, and data integration strategies. In an era where precision matters, the integration of high-resolution imaging with comprehensive transcriptomic profiling has redefined research approaches, providing a detailed map of molecular interactions within their native cellular context.

These shifts are not solely driven by technological innovations but are also catalyzed by an accelerating convergence of multidisciplinary expertise. The blending of biological sciences with data analytics has empowered scientists to create more dynamic and interactive models of cellular behavior. Enhanced computational tools now allow for the manipulation and visualization of highly complex datasets, enabling researchers to simulate cellular responses and delineate intricate molecular pathways with accuracy.

Furthermore, the adoption of automated platforms and improved data integration techniques has increased the throughput of spatial analyses. This surge in analytical capability has led to rapid identification of novel therapeutic targets, especially within intricate disease environments such as cancer and neurodegenerative disorders. As traditional experimental methods are continually being augmented by digital innovations, the field is positioned to transition from observational studies to proactive, data-driven interventions.

Key Segmentation Insights in Spatial Genomics & Transcriptomics

A detailed exploration of the spatial genomics and transcriptomics market reveals insights that are intricately segmented by several critical dimensions. Analysis based on product highlights a market that is distinctly divided among consumables, instruments, and software. Consumables are further scrutinized into assay kits and reagents, each being pivotal for the accuracy and efficiency of experimental protocols. In tandem, instruments are categorized into microscopes and sequencing platforms, showcasing diverse modalities for capturing spatial data with high fidelity. The software category, essential for translating raw data into actionable insights, spans data analysis platforms and visualization tools, reflecting a symbiotic relationship between hardware capabilities and advanced analytics.

Moreover, the market segmentation by sequencing method illustrates a rich diversity with methods ranging from in situ sequencing to multiplexed error-robust fluorescence in situ hybridization, sequential fluorescence in situ hybridization, slide-seq, and spatial transcriptomics. This layered approach underlines increasing specialization, enabling more precise analytical outcomes while supporting nuanced research applications. Segmentation following application further adds dimension by addressing the needs of cancer research, developmental biology, drug discovery, immunology, and neurology, where cancer research itself is broken down into oncology profiling and tumor microenvironment analysis, and drug discovery is redefined by biomarker analysis and therapeutic target identification.

Segmentation by end-user additionally illustrates market dynamics, catering to academic research institutions, clinical research organizations, pharmaceutical and biotechnology companies, and research laboratories. Academic institutions are further divided into biology departments and genomics centers, while research laboratories differentiate into core facilities and private labs. This comprehensive segmentation framework not only aids in identifying tailored research needs but also drives strategic investments for innovation and expansion within the field.

Based on Product, market is studied across Consumables, Instruments, and Software. The Consumables is further studied across Assay Kits and Reagents. The Instruments is further studied across Microscopes and Sequencing Platforms. The Software is further studied across Data Analysis Platforms and Visualization Tools.

Based on Sequencing Method, market is studied across In Situ Sequencing, Multiplexed Error-Robust Fluorescence In Situ Hybridization, Sequential Fluorescence In Situ Hybridization, Slide-seq, and Spatial Transcriptomics.

Based on Application, market is studied across Cancer Research, Developmental Biology, Drug Discovery, Immunology, and Neurology. The Cancer Research is further studied across Oncology Profiling and Tumor Microenvironment Analysis. The Drug Discovery is further studied across Biomarker Analysis and Therapeutic Target Identification.

Based on End-User, market is studied across Academic Research Institutions, Clinical Research Organizations, Pharmaceutical & Biotechnology Companies, and Research Laboratories. The Academic Research Institutions is further studied across Biology Departments and Genomics Centers. The Research Laboratories is further studied across Core Facilities and Private Labs.

Insightful Regional Trends Across the Globe

Geographical insights underscore the importance of regional diversity in accelerating the field of spatial genomics and transcriptomics. In the Americas, robust investments in biotechnological research and a strong presence of leading academic institutions are propelling significant advancements, ensuring the continuous evolution of technology and translational methodologies. The confluence of government initiatives and industrial collaborations in this region is fostering rapid innovation and propelling groundbreaking discoveries.

Across Europe, the Middle East, and Africa, there is a concerted push towards building comprehensive research ecosystems that integrate both academic prowess and commercial agility. This region is witnessing an increasing influx of funding for genomic research, and collaborative networks are emerging as catalysts for cross-border scientific initiatives, bridging traditional research with novel technological platforms. Meanwhile, the Asia-Pacific region is fast becoming a research powerhouse, driven by an expanding pool of skilled talent, strategic government policies, and a rising market demand for innovative diagnostic and therapeutic approaches. The continuous interplay among these regions reflects a dynamic global landscape where regional strengths and strategic investments converge to shape the future of spatial genomics.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, Massachusetts, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Prominent Corporations Driving Innovation

The innovation that fuels spatial genomics and transcriptomics is significantly influenced by key market players whose investments and technological breakthroughs are reshaping the industry landscape. Leaders such as 10x Genomics, Inc. and Agilent Technologies, Inc. are at the forefront, driving advancements through cutting-edge sequencing platforms and integrated analytical tools. Other influential companies, including Akoya Biosciences, Inc. and Becton, Dickinson and Company, have also laid important groundwork with innovative approaches to spatial profiling and robust instrumentation.

In addition, companies like Bio-Rad Laboratories, Inc. and Bio-Techne Corporation have pushed the envelope by introducing novel consumables and reagents that are critical for enhancing assay accuracy and efficiency. Corporations such as Bruker Corporation and Carl Zeiss AG are redefining imaging techniques with state-of-the-art microscope systems, while Danaher Corporation and Evident Corporation continue to strengthen the market with innovative data processing and visualization solutions.

Prominent entities like Illumina, Inc., Indica Labs, Inc., and Ionpath, Inc. complement this ecosystem through their research-driven products that bridge the gap between laboratory research and comprehensive clinical analysis. Other companies, including Merck KGaA, Parse Biosciences, and PerkinElmer, Inc., have made considerable strides by optimizing both the throughput and precision of spatial analyses. Furthermore, emerging players such as RareCyte, Inc., Rebus Biosystems, Inc., Resolve Biosciences GmbH., S2 Genomics, Inc., Seven Bridges Genomics, Standard BioTools Inc., Thermo Fisher Scientific Inc., Ultivue, Inc., and Vizgen Inc. consistently contribute to the competitive spirit and innovative progress within the sector.

The report delves into recent significant developments in the Spatial Genomics & Transcriptomics Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., Agilent Technologies, Inc., Akoya Biosciences, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Bruker Corporation, Carl Zeiss AG, Danaher Corporation, Evident Corporation, Illumina, Inc., Indica Labs, Inc., Ionpath, Inc., Merck KGaA, Parse Biosciences, PerkinElmer, Inc., RareCyte, Inc., Rebus Biosystems, Inc., Resolve Biosciences GmbH., S2 Genomics, Inc., Seven Bridges Genomics, Standard BioTools Inc., Thermo Fisher Scientific Inc., Ultivue, Inc., and Vizgen Inc..

Actionable Recommendations for Industry Leaders

Industry leaders have a unique opportunity to harness the rapidly expanding potential of spatial genomics and transcriptomics. It is recommended that organizations strategically invest in next-generation technologies that offer not only enhanced resolution but also the integration of robust data analytics. Leaders should prioritize the development of multi-disciplinary teams that combine expertise in molecular biology, computational science, and clinical research to drive innovation from the bench to bedside.

Additionally, fostering collaborative partnerships across academia, clinical research centers, and private industry is paramount. By aligning complimentary strengths and sharing cutting-edge methodologies, stakeholders can streamline the process of translating experimental data into real-world diagnostic and therapeutic solutions. Industry leaders are also advised to continuously monitor emerging trends and invest in modular platforms that can adapt as technological paradigms shift. This agile approach will enable institutions to remain ahead in a competitive market landscape and ensure that their investment in cutting-edge technology yields sustainable long-term growth.

Comprehensive Conclusion Summarizing the Research

In conclusion, spatial genomics and transcriptomics are redefining the frontier of biomedical research by merging high-resolution imaging with advanced sequencing techniques. This convergence is enabling researchers to capture the spatial context of complex biological systems in a manner that leads to precise diagnostics and innovative therapies. Through meticulous segmentation by product, sequencing method, application, and end-user, the field has provided nuanced insights that help pinpoint areas of clinical and research significance. Furthermore, regional trends and the dynamic contributions from key market players underscore a rapidly evolving industry that is both diverse and interconnected.

As the field continues to progress, the amalgamation of high-quality experimental data with advanced analytics will further empower researchers, ultimately translating scientific discovery into tangible improvements in patient care and clinical outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of chronic diseases drives demand for advanced spatial genomic solutions
5.1.1.2. Increasing applications of spatial genomics and transcriptomics in personalized medicine
5.1.1.3. Growing emphasis on early detection and diagnosis fueling innovations in spatial genomics
5.1.2. Restraints
5.1.2.1. Limitations in capturing high-resolution spatial data within reasonable timeframes
5.1.3. Opportunities
5.1.3.1. Developments in microscopy and imaging techniques enhancing spatial resolution and accuracy in genomics studies
5.1.3.2. Increased funding for genomics research boosting developments in spatial transcriptomics studies
5.1.4. Challenges
5.1.4.1. Reimbursement inconsistency and uncertainty in gene & single-cell sequencing
5.2. Market Segmentation Analysis
5.2.1. Product: Increasing usage for assay kits in laboratories due to their high throughput and accuracy
5.2.2. Sequencing Method: Utilization of slide-seq due to high-resolution spatial maps of gene expression, providing critical insights
5.2.3. Application: Adoption of spatial genomics in accelerating drug discovery and development
5.2.4. End-User: Preference for clinical research organizations enhancing precision in clinical trials
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Spatial Genomics & Transcriptomics Market, by Product
6.1. Introduction
6.2. Consumables
6.2.1. Assay Kits
6.2.2. Reagents
6.3. Instruments
6.3.1. Microscopes
6.3.2. Sequencing Platforms
6.4. Software
6.4.1. Data Analysis Platforms
6.4.2. Visualization Tools
7. Spatial Genomics & Transcriptomics Market, by Sequencing Method
7.1. Introduction
7.2. In Situ Sequencing
7.3. Multiplexed Error-Robust Fluorescence In Situ Hybridization
7.4. Sequential Fluorescence In Situ Hybridization
7.5. Slide-seq
7.6. Spatial Transcriptomics
8. Spatial Genomics & Transcriptomics Market, by Application
8.1. Introduction
8.2. Cancer Research
8.2.1. Oncology Profiling
8.2.2. Tumor Microenvironment Analysis
8.3. Developmental Biology
8.4. Drug Discovery
8.4.1. Biomarker Analysis
8.4.2. Therapeutic Target Identification
8.5. Immunology
8.6. Neurology
9. Spatial Genomics & Transcriptomics Market, by End-User
9.1. Introduction
9.2. Academic Research Institutions
9.2.1. Biology Departments
9.2.2. Genomics Centers
9.3. Clinical Research Organizations
9.4. Pharmaceutical & Biotechnology Companies
9.5. Research Laboratories
9.5.1. Core Facilities
9.5.2. Private Labs
10. Americas Spatial Genomics & Transcriptomics Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Spatial Genomics & Transcriptomics Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Spatial Genomics & Transcriptomics Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Vizgen launch CSP program to broaden single-cell spatial genomics access
13.3.2. Complete Genomics announces exclusive agreement with STOmics spatial transcriptomics and launches spatial Xcellerator grant
13.3.3. Vizgen and Ultivue announce merger to propel innovation in spatial genomics and proteomics
13.3.4. Lunaphore partners with Discovery Life Sciences to bring innovative spatial biology solutions to clinical research
13.3.5. Deerfield proposes acquisition of Singular Genomics to enhance strategic growth in genomics and multiomics technologies
13.3.6. Moleculent secures USD 26 million in series A funding to propel innovations in spatial genomics and transcriptomics
13.3.7. Bruker acquires NanoString spatial biology business to enhance genomic solutions
13.3.8. 10x Genomics launch Visium HD for advanced single cell-scale spatial transcriptome analysis
13.3.9. DNAnexus and Curio Bioscience collaborate to enhance data analysis for spatial transcriptomics projects
13.3.10. Singular Genomics launches G4X spatial sequencer to enhancing multiomic analysis efficiency
13.4. Strategy Analysis & Recommendation
13.4.1. Becton, Dickinson and Company
13.4.2. Agilent Technologies, Inc.
13.4.3. Bruker Corporation
13.4.4. 10x Genomics, Inc.
List of Figures
FIGURE 1. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET MULTI-CURRENCY
FIGURE 2. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET MULTI-LANGUAGE
FIGURE 3. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET RESEARCH PROCESS
FIGURE 4. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, 2023 VS 2030
FIGURE 5. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 6. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 9. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2023 VS 2030 (%)
FIGURE 11. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 13. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 15. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 19. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 25. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET DYNAMICS
TABLE 7. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY MICROSCOPES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DATA ANALYSIS PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY VISUALIZATION TOOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY IN SITU SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY MULTIPLEXED ERROR-ROBUST FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENTIAL FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SLIDE-SEQ, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ONCOLOGY PROFILING, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TUMOR MICROENVIRONMENT ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DEVELOPMENTAL BIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY BIOMARKER ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY THERAPEUTIC TARGET IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY BIOLOGY DEPARTMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY GENOMICS CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CORE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRIVATE LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 83. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 85. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 86. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 87. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 88. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 90. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 91. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 92. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 93. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 94. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 95. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 96. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 97. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 98. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 99. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 101. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 102. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 104. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 112. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 115. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 116. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 117. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 118. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 119. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 120. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 121. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 122. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 124. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 125. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 127. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 128. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 129. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 130. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 131. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 132. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 133. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 134. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 136. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 137. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 139. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 140. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 142. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 143. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 144. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 145. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 147. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 148. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 149. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 150. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 151. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 152. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 153. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 154. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 155. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 156. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 158. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 159. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 160. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 161. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 162. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 163. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 164. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 165. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 166. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 167. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 169. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 170. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 171. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 172. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 173. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 174. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 175. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 176. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 177. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 178. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 180. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 181. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 182. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 183. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 184. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 185. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 186. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 187. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 188. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 189. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 191. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 192. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 193. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 194. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 195. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 196. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 197. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 198. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 199. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 200. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 202. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 203. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 204. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 205. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 206. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 207. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 208. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 209. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 210. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 211. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 213. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 214. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 215. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 216. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 217. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 218. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 219. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 220. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 221. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 222. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 224. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 225. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 226. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 227. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 228. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 229. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 230. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 231. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 232. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 233. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 235. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 236. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 237. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 238. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 239. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 240. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 241. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 242. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 243. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 244. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 246. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 247. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 248. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 249. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 250. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 251. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 252. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 253. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 254. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 255. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 256. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 257. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 258. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 259. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 260. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 273. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 274. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 275. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 276. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 277. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 278. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 279. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 280. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 281. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 282. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 283. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 284. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 285. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 286. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 287. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 288. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
TABLE 289. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 290. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
TABLE 291. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 292. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 293. EGYPT SPATIAL GENOMICS & TRANS

Companies Mentioned

  • 10x Genomics, Inc.
  • Agilent Technologies, Inc.
  • Akoya Biosciences, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Bruker Corporation
  • Carl Zeiss AG
  • Danaher Corporation
  • Evident Corporation
  • Illumina, Inc.
  • Indica Labs, Inc.
  • Ionpath, Inc.
  • Merck KGaA
  • Parse Biosciences
  • PerkinElmer, Inc.
  • RareCyte, Inc.
  • Rebus Biosystems, Inc.
  • Resolve Biosciences GmbH.
  • S2 Genomics, Inc.
  • Seven Bridges Genomics
  • Standard BioTools Inc.
  • Thermo Fisher Scientific Inc.
  • Ultivue, Inc.
  • Vizgen Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages199
PublishedMarch 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 1.18 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.38 Billion
Compound Annual Growth Rate12.3%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Spatial Transcriptomics & Genomics Market - Global Outlook & Forecast 2025-2030 - Product Image

Spatial Transcriptomics & Genomics Market - Global Outlook & Forecast 2025-2030

  • Report
  • 362 Pages
  • Global
From
Spatial Genomics and Transcriptomics Market Report and Forecast 2024-2032 - Product Image

Spatial Genomics and Transcriptomics Market Report and Forecast 2024-2032

  • Report
  • 200 Pages
  • Global
From
Spatial Genomics & Transcriptomics Market by Product (Instruments, Consumables, Services), Technique (Transcriptomics (IHC, ISH), Genomics (LCM), Service Type (Sample Prep, Sequencing), Application (Translation Research (Cancer)) - Global Forecast to 2029 - Product Image

Spatial Genomics & Transcriptomics Market by Product (Instruments, Consumables, Services), Technique (Transcriptomics (IHC, ISH), Genomics (LCM), Service Type (Sample Prep, Sequencing), Application (Translation Research (Cancer)) - Global Forecast to 2029

  • Report
  • 450 Pages
  • Global
From
Spatial Genomics and Transcriptomics - Global Strategic Business Report - Product Image

Spatial Genomics and Transcriptomics - Global Strategic Business Report

  • Report
  • 89 Pages
  • Global
From
Spatial Transcriptomics Market Size, Share & Trends Analysis Report by Products (Instruments, Consumables, Software), Technology (Sequencing-Based Methods), Workflow, Sample Type, End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

Spatial Transcriptomics Market Size, Share & Trends Analysis Report by Products (Instruments, Consumables, Software), Technology (Sequencing-Based Methods), Workflow, Sample Type, End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 119 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.